Roy Beveridge

2.1k total citations
62 papers, 1.5k citations indexed

About

Roy Beveridge is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roy Beveridge has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 14 papers in Economics and Econometrics and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roy Beveridge's work include Economic and Financial Impacts of Cancer (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Cancer Treatment and Pharmacology (7 papers). Roy Beveridge is often cited by papers focused on Economic and Financial Impacts of Cancer (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers) and Cancer Treatment and Pharmacology (7 papers). Roy Beveridge collaborates with scholars based in United States, United Kingdom and Romania. Roy Beveridge's co-authors include Nancy E. Davidson, Martin D. Abeloff, J. Russell Hoverman, Michael Kolodziej, Marcus A. Neubauer, Gary Gordon, Robert M. Rifkin, J. Cameron Muir, Richard L. Weinberg and Lonny Reisman and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Roy Beveridge

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy Beveridge United States 22 658 284 233 231 222 62 1.5k
Andrea Denicoff United States 22 801 1.2× 385 1.4× 147 0.6× 280 1.2× 248 1.1× 69 1.5k
Barry Meisenberg United States 21 837 1.3× 230 0.8× 238 1.0× 299 1.3× 91 0.4× 68 1.9k
Ned Calonge United States 20 484 0.7× 269 0.9× 247 1.1× 211 0.9× 179 0.8× 55 1.8k
Donna R. Rivera United States 17 542 0.8× 204 0.7× 173 0.7× 140 0.6× 184 0.8× 93 1.2k
Sidney Scudder United States 20 603 0.9× 397 1.4× 286 1.2× 406 1.8× 246 1.1× 49 1.9k
George Dranitsaris Canada 28 774 1.2× 108 0.4× 313 1.3× 350 1.5× 449 2.0× 105 2.3k
Thomas E. Delea United States 26 763 1.2× 133 0.5× 181 0.8× 298 1.3× 378 1.7× 136 2.4k
Richard S. Ungerleider United States 18 756 1.1× 712 2.5× 232 1.0× 639 2.8× 404 1.8× 37 2.3k
Carol M. Richman United States 21 359 0.5× 433 1.5× 103 0.4× 158 0.7× 243 1.1× 55 1.4k
Kevin Knopf United States 20 772 1.2× 154 0.5× 132 0.6× 131 0.6× 285 1.3× 73 1.7k

Countries citing papers authored by Roy Beveridge

Since Specialization
Citations

This map shows the geographic impact of Roy Beveridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Beveridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Beveridge more than expected).

Fields of papers citing papers by Roy Beveridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Beveridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Beveridge. The network helps show where Roy Beveridge may publish in the future.

Co-authorship network of co-authors of Roy Beveridge

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Beveridge. A scholar is included among the top collaborators of Roy Beveridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Beveridge. Roy Beveridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verrilli, Diana K., et al.. (2015). Cost differential by site of service for cancer patients receiving chemotherapy.. PubMed. 21(3). e189–96. 14 indexed citations
2.
Herman, William H., et al.. (2014). Achieving the Meaningful Use Standard: A Model for Implementing Change Within Medical Practices. Journal of Oncology Practice. 10(2). 105–105. 1 indexed citations
3.
Hoverman, J. Russell, et al.. (2013). Defining Cancer Care Quality or Delivering Quality Cancer Care?. Journal of the National Comprehensive Cancer Network. 11(2). 121–124. 5 indexed citations
4.
Beveridge, Roy, John Fox, Susan A. Higgins, et al.. (2013). Roundtable—The Changing Oncology Landscape: Evolution or Revolution?. Journal of the National Comprehensive Cancer Network. 11(5S). 636–638. 3 indexed citations
5.
Benson, Al B., et al.. (2012). Defining Value in Cancer Care: AVBCC 2012 Steering Committee Report.. PubMed. 5(4). 202–17. 1 indexed citations
6.
Giralt, Sergio, Kenneth F. Mangan, Richard T. Maziarz, et al.. (2010). Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation. Annals of Oncology. 22(4). 939–946. 30 indexed citations
7.
Muir, J. Cameron, et al.. (2010). Integrating Palliative Care Into the Outpatient, Private Practice Oncology Setting. Journal of Pain and Symptom Management. 40(1). 126–135. 96 indexed citations
8.
Beveridge, Roy, et al.. (2003). Impact of Long‐Acting Growth Factors on Practice Dynamics and Patient Satisfaction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(12P2). 101S–109S. 33 indexed citations
9.
Schuster, Michael W., Roy Beveridge, Debra Frei‐Lahr, et al.. (2002). The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation. Experimental Hematology. 30(9). 1044–1050. 24 indexed citations
10.
Winston, D. J., Hillard M. Lazarus, Roy Beveridge, et al.. (2001). Randomized, Double-Blind, Multicenter Trial Comparing Clinafloxacin with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients. Clinical Infectious Diseases. 32(3). 381–390. 37 indexed citations
11.
Boyle, Deborah, et al.. (2000). Caregiver Quality of Life After Autologous Bone Marrow Transplantation. Cancer Nursing. 23(3). 193–203. 46 indexed citations
12.
Weiss, Raymond B., Robert M. Rifkin, F. Marc Stewart, et al.. (2000). High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study. The Lancet. 355(9208). 999–1003. 92 indexed citations
13.
Vogler, William R., Wolfgang E. Berdel, Robert B. Geller, et al.. (1996). A Phase II Trial of Autologous Bone Marrow Transplantation (ABMT) in Acute Leukemia with Edelfosine Purged Bone Marrow. Advances in experimental medicine and biology. 416. 389–396. 26 indexed citations
14.
Chan, Daniel W., Roy Beveridge, Arvind K. Bhargava, et al.. (1994). Breast Cancer Marker CA549:A Multicenter Study. American Journal of Clinical Pathology. 101(4). 465–470. 10 indexed citations
15.
Schwartz, Richard H. & Roy Beveridge. (1994). Marijuana as an Antiemetic Drug:. Journal of Addictive Diseases. 13(1). 53–65. 25 indexed citations
16.
John, Esther M., Georgia B. Vogelsang, Roy Beveridge, et al.. (1993). Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.. Journal of Clinical Oncology. 11(3). 478–484. 58 indexed citations
17.
Beveridge, Roy, et al.. (1991). High-Dose Chemotherapy With Reinfusion of Purged Autologous Bone Marrow Following Dose-Intense Induction as Initial Therapy for Metastatic Breast Cancer. JNCI Journal of the National Cancer Institute. 83(13). 920–926. 131 indexed citations
18.
Abeloff, Martin D., Roy Beveridge, Ross C. Donehower, et al.. (1990). Sixteen-Week Dose-Intense Chemotherapy in the Adjuvant Treatment of Breast Cancer. JNCI Journal of the National Cancer Institute. 82(7). 570–574. 33 indexed citations
19.
Lindsay, Pete, et al.. (1990). Patient-recorded domiciliary fetal monitoring. American Journal of Obstetrics and Gynecology. 162(2). 466–470. 6 indexed citations
20.
Ferguson, Mark K., Alex G. Little, Harvey M. Golomb, et al.. (1986). The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 91(3). 344–349. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Denicoff Breakdown of academic impact, for papers by Barry Meisenberg Breakdown of academic impact, for papers by Ned Calonge Breakdown of academic impact, for papers by Donna R. Rivera Breakdown of academic impact, for papers by Sidney Scudder Breakdown of academic impact, for papers by George Dranitsaris Breakdown of academic impact, for papers by Thomas E. Delea Breakdown of academic impact, for papers by Richard S. Ungerleider Breakdown of academic impact, for papers by Carol M. Richman Breakdown of academic impact, for papers by Kevin Knopf
Rankless by CCL
2026